Screener
D&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Medpace Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001668397-26-000025
| (Amounts in thousands, except per share amounts) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Reimbursed out-of-pocket expenses | 303,139 | 237,472 | 615,143 | 439,876 |
| Total direct costs | 505,694 | 423,298 | 1,015,972 | 803,518 |
| Selling, general and administrative | 48,103 | 46,664 | 96,020 | 104,561 |
| Depreciation | 6,555 | 6,777 | 13,306 | 13,471 |
| Amortization | 155 | 237 | 310 | 473 |
| Total operating expenses | 560,507 | 476,976 | 1,125,608 | 922,023 |
| Income from operations | 146,824 | 126,335 | 288,327 | 239,858 |
| Other income (expense), net: |
Item 1. Financial Statements (unaudited)
FAQ
- What is Medpace Holdings, Inc.'s D&A?
- Medpace Holdings, Inc. (MEDP) reported D&A of $6.56M in Q2 2026.
- How has Medpace Holdings, Inc.'s D&A changed year-over-year?
- Medpace Holdings, Inc.'s D&A decreased by 3.3% year-over-year, from $6.78M to $6.56M.
- What is the long-term trend for Medpace Holdings, Inc.'s D&A?
- Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s D&A has grown at a 14.2% compound annual growth rate (CAGR), from $16.01M to $27.18M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about Medpace Holdings, Inc.'s d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude